相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Therapeutic Targeting of Oncogenic K-Ras by a Covalent Catalytic Site Inhibitor
Sang Min Lim et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Identification of protein phosphatase 1 as a regulator of the LRRK2 phosphorylation cycle
Evy Lobbestael et al.
BIOCHEMICAL JOURNAL (2013)
Differential Effects of Familial Parkinson Mutations in LRRK2 Revealed by a Systematic Analysis of Autophosphorylation
Shogo Kamikawaji et al.
BIOCHEMISTRY (2013)
Type II Kinase Inhibitors Show an Unexpected Inhibition Mode against Parkinson's Disease-Linked LRRK2 Mutant G2019S
Min Liu et al.
BIOCHEMISTRY (2013)
LRRK2 guides the actin cytoskeleton at growth cones together with ARHGEF7 and Tropomyosin 4
Karina Haebig et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
GTPase activity regulates kinase activity and cellular phenotypes of Parkinson's disease-associated LRRK2
Alice Biosa et al.
HUMAN MOLECULAR GENETICS (2013)
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
Jonathan M. Ostrem et al.
NATURE (2013)
Interplay of LRRK2 with chaperone-mediated autophagy
Samantha J. Orenstein et al.
NATURE NEUROSCIENCE (2013)
Expression Analysis of Lrrk1, Lrrk2 and Lrrk2 Splice Variants in Mice
Florian Giesert et al.
PLOS ONE (2013)
A Competitive Nucleotide Binding Inhibitor: In Vitro Characterization of Rab7 GTPase Inhibition
Jacob O. Agola et al.
ACS CHEMICAL BIOLOGY (2012)
Re-examination of the dimerization state of leucine-rich repeat kinase 2: predominance of the monomeric form
Genta Ito et al.
BIOCHEMICAL JOURNAL (2012)
The G2385R variant of leucine-rich repeat kinase 2 associated with Parkinson's disease is a partial loss-of-function mutation
Iakov N. Rudenko et al.
BIOCHEMICAL JOURNAL (2012)
Role of LRRK2 kinase activity in the pathogenesis of Parkinson's disease
Elisa Greggio
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
LRRK2 GTPase dysfunction in the pathogenesis of Parkinson's disease
Yulan Xiong et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Phosphorylation of LRRK2: from kinase to substrate
Evy Lobbestael et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Analysis of LRRK2 accessory repeat domains: prediction of repeat length, number and sites of Parkinson's disease mutations
Ryan D. Mills et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Expression, purification and preliminary biochemical and structural characterization of the leucine rich repeat namesake domain of leucine rich repeat kinase 2
Renee Vancraenenbroeck et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2012)
Number and Brightness Analysis of LRRK2 Oligomerization in Live Cells
Nicholas G. James et al.
BIOPHYSICAL JOURNAL (2012)
(G2019S) LRRK2 activates MKK4-JNK pathway and causes degeneration of SN dopaminergic neurons in a transgenic mouse model of PD
C-Y Chen et al.
CELL DEATH AND DIFFERENTIATION (2012)
Neurodegenerative diseases: challenges and opportunities FOREWORD
Gregory D. Cuny
FUTURE MEDICINAL CHEMISTRY (2012)
ArfGAP1 Is a GTPase Activating Protein for LRRK2: Reciprocal Regulation of ArfGAP1 by LRRK2
Yulan Xiong et al.
JOURNAL OF NEUROSCIENCE (2012)
LRRK2 Controls an EndoA Phosphorylation Cycle in Synaptic Endocytosis
Samer Matta et al.
NEURON (2012)
The IkappaB Kinase Family Phosphorylates the Parkinson's Disease Kinase LRRK2 at Ser935 and Ser910 during Toll-Like Receptor Signaling
Nicolas Dzamko et al.
PLOS ONE (2012)
Biochemical Characterization of Highly Purified Leucine-Rich Repeat Kinases 1 and 2 Demonstrates Formation of Homodimers
Laura Civiero et al.
PLOS ONE (2012)
Sequences Located within the N-Terminus of the PD-Linked LRRK2 Lead to Increased Aggregation and Attenuation of 6-Hydroxydopamine-Induced Cell Death
Neeraj Pandey et al.
PLOS ONE (2012)
Roco kinase structures give insights into the mechanism of Parkinson disease-related leucine-rich-repeat kinase 2 mutations
Bernd K. Gilsbach et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Ser1292 Autophosphorylation Is an Indicator of LRRK2 Kinase Activity and Contributes to the Cellular Effects of PD Mutations
Zejuan Sheng et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
GTPase Activity and Neuronal Toxicity of Parkinson's Disease-Associated LRRK2 Is Regulated by ArfGAP1
Klodjan Stafa et al.
PLOS GENETICS (2012)
Chemoproteomics-Based Design of Potent LRRK2-Selective Lead Compounds That Attenuate Parkinson's Disease-Related Toxicity in Human Neurons
Nigel Ramsden et al.
ACS CHEMICAL BIOLOGY (2011)
Structure-Function Relationships of the G Domain, a Canonical Switch Motif
Alfred Wittinghofer et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 80 (2011)
The Evolution of Protein Kinase Inhibitors from Antagonists to Agonists of Cellular Signaling
Arvin C. Dar et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 80 (2011)
Kinetic, Mechanistic, and Structural Modeling Studies of Truncated Wild-Type Leucine-Rich Repeat Kinase 2 and the G2019S Mutant
Min Liu et al.
BIOCHEMISTRY (2011)
The importin β binding domain as a master regulator of nucleocytoplasmic transport
Kaylen Lott et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
LRRK2 directly phosphorylates Akt1 as a possible physiological substrate: Impairment of the kinase activity by Parkinson's disease-associated mutations
Etsuro Ohta et al.
FEBS LETTERS (2011)
Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant
Veronique Daniels et al.
JOURNAL OF NEUROCHEMISTRY (2011)
LRRK2 Controls Synaptic Vesicle Storage and Mobilization within the Recycling Pool
Giovanni Piccoli et al.
JOURNAL OF NEUROSCIENCE (2011)
Association of LRRK2 exonic variants and susceptibility to Parkinson's disease: a case-control study (vol 10, pg 898, 2011)
O. A. Ross et al.
LANCET NEUROLOGY (2011)
On the Road to Leucine-Rich Repeat Kinase 2 Signalling: Evidence from Cellular and in vivo Studies
V. Daniels et al.
NEUROSIGNALS (2011)
Phosphorylation-Dependent 14-3-3 Binding to LRRK2 Is Impaired by Common Mutations of Familial Parkinson's Disease
Xianting Li et al.
PLOS ONE (2011)
LRRK2 Kinase Activity Is Dependent on LRRK2 GTP Binding Capacity but Independent of LRRK2 GTP Binding
Jean-Marc Taymans et al.
PLOS ONE (2011)
Crystal Structures of the Armadillo Repeat Domain of Adenomatous Polyposis Coli and Its Complex with the Tyrosine-Rich Domain of Sam68
Ella Czarina Morishita et al.
STRUCTURE (2011)
Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study
Owen A. Ross et al.
LANCET NEUROLOGY (2011)
Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localization
Nicolas Dzamko et al.
BIOCHEMICAL JOURNAL (2010)
14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization
R. Jeremy Nichols et al.
BIOCHEMICAL JOURNAL (2010)
Kinetic Mechanistic Studies of Wild-Type Leucine-Rich Repeat Kinase2: Characterization of the Kinase and GTPase Activities
Min Liu et al.
BIOCHEMISTRY (2010)
Membrane Localization of LRRK2 Is Associated with Increased Formation of the Highly Active LRRK2 Dimer and Changes in Its Phosphorylation
Zdenek Berger et al.
BIOCHEMISTRY (2010)
Expression, purification and preliminary biochemical studies of the N-terminal domain of leucine-rich repeat kinase 2
Bin Lu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
Defining the conserved internal architecture of a protein kinase
Alexandr P. Kornev et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
Dynamic and Static Interactions between p120 Catenin and E-Cadherin Regulate the Stability of Cell-Cell Adhesion
Noboru Ishiyama et al.
CELL (2010)
Genetic Etiology of Parkinson Disease Associated with Mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 Genes: A Mutation Update
Karen Nuytemans et al.
HUMAN MUTATION (2010)
Reevaluation of Phosphorylation Sites in the Parkinson Disease-associated Leucine-rich Repeat Kinase 2
Xiaojie Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Through the Gatekeeper Door: Exploiting the Active Kinase Conformation
Fabio Zuccotto et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
MKK6 binds and regulates expression of Parkinson's disease-related protein LRRK2
Cindy H. Hsu et al.
JOURNAL OF NEUROCHEMISTRY (2010)
LRRK2 Kinase Regulates Synaptic Morphology through Distinct Substrates at the Presynaptic and Postsynaptic Compartments of the Drosophila Neuromuscular Junction
Seongsoo Lee et al.
JOURNAL OF NEUROSCIENCE (2010)
Enhanced Striatal Dopamine Transmission and Motor Performance with LRRK2 Overexpression in Mice Is Eliminated by Familial Parkinson's Disease Mutation G2019S
Xianting Li et al.
JOURNAL OF NEUROSCIENCE (2010)
Phosphopeptide Analysis Reveals Two Discrete Clusters of Phosphorylation in the N-Terminus and the Roc Domain of the Parkinson-Disease Associated Protein Kinase LRRK2
Christian Johannes Gloeckner et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Dynamics connect substrate recognition to catalysis in protein kinase A
Larry R. Masterson et al.
NATURE CHEMICAL BIOLOGY (2010)
Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
Byoung Dae Lee et al.
NATURE MEDICINE (2010)
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
Mark R. Cookson
NATURE REVIEWS NEUROSCIENCE (2010)
LRRK2 and the Stress Response: Interaction with MKKs and JNK-Interacting Proteins
C. H. Hsu et al.
NEURODEGENERATIVE DISEASES (2010)
ARHGEF7 (BETA-PIX) Acts as Guanine Nucleotide Exchange Factor for Leucine-Rich Repeat Kinase 2
Karina Haebig et al.
PLOS ONE (2010)
Identification and Characterization of a Leucine-Rich Repeat Kinase 2 (LRRK2) Consensus Phosphorylation Motif
Pooja P. Pungaliya et al.
PLOS ONE (2010)
Structural and functional analysis of the interaction between the nucleoporin Nup98 and the mRNA export factor Rae1
Yi Ren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Deletion of the WD40 Domain of LRRK2 in Zebrafish Causes Parkinsonism-Like Loss of Neurons and Locomotive Defect
Donglai Sheng et al.
PLOS GENETICS (2010)
GTPase Activity Plays a Key Role in the Pathobiology of LRRK2
Yulan Xiong et al.
PLOS GENETICS (2010)
Lrrk2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications
Hong Qing et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Identification of compounds that inhibit the kinase activity of leucine-rich repeat kinase 2
Jason P. Covy et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
The Parkinson's disease kinase LRRK2 autophosphorylates its GTPase domain at multiple sites
Elisa Greggio et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease
R. Jeremy Nichols et al.
BIOCHEMICAL JOURNAL (2009)
Structural aspects of Rab6-effector complexes
Humberto Fernandes et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2009)
Investigation of leucine-rich repeat kinase 2
Vasanti S. Anand et al.
FEBS JOURNAL (2009)
Dependence of Leucine-rich Repeat Kinase 2 (LRRK2) Kinase Activity on Dimerization
Saurabh Sen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Abnormal Localization of Leucine-Rich Repeat Kinase 2 to the Endosomal-Lysosomal Compartment in Lewy Body Disease
Shinji Higashi et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Phosphorylation of Ezrin/Radixin/Moesin Proteins by LRRK2 Promotes the Rearrangement of Actin Cytoskeleton in Neuronal Morphogenesis
Loukia Parisiadou et al.
JOURNAL OF NEUROSCIENCE (2009)
Parkin Protects against LRRK2 G2019S Mutant-Induced Dopaminergic Neurodegeneration in Drosophila
Chee-Hoe Ng et al.
JOURNAL OF NEUROSCIENCE (2009)
Genotypic and Phenotypic Characteristics of Dutch Patients with Early Onset Parkinson's Disease
Maria G. Macedo et al.
MOVEMENT DISORDERS (2009)
The WD40 Domain Is Required for LRRK2 Neurotoxicity
Nathan D. Jorgensen et al.
PLOS ONE (2009)
R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice
Youren Tong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Structural Basis of UV DNA-Damage Recognition by the DDB1-DDB2 Complex
Andrea Scrima et al.
CELL (2008)
The leucine-rich repeat structure
J. Bella et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Understanding and exploiting substrate recognition by protein kinases
Benjamin E. Turk
CURRENT OPINION IN CHEMICAL BIOLOGY (2008)
Structure of the Roc-COR domain tandem of C. tepidum, a prokaryotic homologue of the human LRRK2 Parkinson kinase (vol 27, pg 2239, 2008)
Katja Gotthardt et al.
EMBO JOURNAL (2008)
Structure of the Roc-COR domain tandem of C-tepidum, a prokaryotic homologue of the human LRRK2 Parkinson kinase
Katja Gotthardt et al.
EMBO JOURNAL (2008)
LRRK2 regulates synaptic vesicle endocytosis
Narae Shin et al.
EXPERIMENTAL CELL RESEARCH (2008)
Structural basis of histone H4 recognition by p55
Ji-Joon Song et al.
GENES & DEVELOPMENT (2008)
Comprehensive analysis of LRRK2 in publicly available Parkinson's disease cases and neurologically normal controls
Coro Paisan-Ruiz et al.
HUMAN MUTATION (2008)
Intramolecular Activation Mechanism of theDictyosteliumLRRK2 Homolog Roco Protein GbpC
Wouter N. van Egmond et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation
Elisa Greggio et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells
Edward D. Plowey et al.
JOURNAL OF NEUROCHEMISTRY (2008)
A helix scaffold for the assembly of active protein kinases
Alexandr P. Kornev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A Drosophila model for LRRK2-linked parkinsonism
Zhaohui Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase
Junpeng Deng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8
W. C. Nichols et al.
NEUROLOGY (2007)
Vaccinia-related kinase 2 modulates the stress response to hypoxia mediated by TAK1
Sandra Blanco et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity
Luxuan Guo et al.
EXPERIMENTAL CELL RESEARCH (2007)
Mechanistic insight into the dominant mode of the Parkinson's disease-associated G2019S LRRK2 mutation
Berta Luzon-Toro et al.
HUMAN MOLECULAR GENETICS (2007)
Mechanisms of specificity in protein phosphorylation (vol 8, pg 530, 2007)
Jeffrey A. Ubersax et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity
Mahaboobi Jaleel et al.
BIOCHEMICAL JOURNAL (2007)
Mechanisms of specificity in protein phosphorylation
Jeffrey A. Ubersax et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Pathogenic mutations in Parkinson disease
Eng-King Tan et al.
HUMAN MUTATION (2007)
Independent occurrence of I2020T mutation in the kinase domain of the leucine rich repeat kinase 2 gene in Japanese and German Parkinson's disease families
Etsuro Ohta et al.
NEUROSCIENCE LETTERS (2007)
Structure of a Fbw7-Skp1-cyclin E complex: Multisite-phosphorylated substrate recognition by SCF ubiquitin ligases
Bing Hao et al.
MOLECULAR CELL (2007)
GTP binding is essential to the protein kinase activity of LRRK2, a causative gene product for familial Parkinson's disease
Genta Ito et al.
BIOCHEMISTRY (2007)
Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity
Andrew B. West et al.
HUMAN MOLECULAR GENETICS (2007)
Screening for SNCA and LRRK2 mutations in Greek sporadic and autosomal dominant Parkinson's disease: identification of two novel LRRK2 variants
G. Xiromerisiou et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families
Lianna Ishihara et al.
MOVEMENT DISORDERS (2007)
Ankyrin repeat: A unique motif mediating protein-protein interactions
Junan Li et al.
BIOCHEMISTRY (2006)
A common genetic factor for Parkinson disease in ethnic Chinese population in Taiwan
Hon-Chung Fung et al.
BMC NEUROLOGY (2006)
The Parkinson disease gene LRRK2:: Evolutionary and structural insights
Ignacio Marin
MOLECULAR BIOLOGY AND EVOLUTION (2006)
C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1
Chou Hung Sim et al.
HUMAN MOLECULAR GENETICS (2006)
Kinase activity of mutant LRRK2 mediates neuronal toxicity
Wanli W. Smith et al.
NATURE NEUROSCIENCE (2006)
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin
Elisa Greggio et al.
NEUROBIOLOGY OF DISEASE (2006)
A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan
Alessio Di Fonzo et al.
NEUROGENETICS (2006)
Crystal structure of the biglycan dimer and evidence that dimerization is essential for folding and stability of class I small leucine-rich repeat proteoglycans
PG Scott et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
LRRK2 in Parkinson's disease: protein domains and functional insights
Ignacio F. Mata et al.
TRENDS IN NEUROSCIENCES (2006)
Lrrk2 pathogenic substitutions in Parkinson's disease
IF Mata et al.
NEUROGENETICS (2005)
Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease:: clinical, pathological, olfactory and functional imaging and genetic data
NL Khan et al.
BRAIN (2005)
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
AB West et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Analysis of LRRK2 functional domains in nondominant Parkinson disease
L Skipper et al.
NEUROLOGY (2005)
Crystal structure of human Toll-like receptor 3 (TLR3) ectodomain
J Choe et al.
SCIENCE (2005)
An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family
M Funayama et al.
ANNALS OF NEUROLOGY (2005)
Structural basis of Rho GTPase-mediated activation of the formin rnDia1
T Otomo et al.
MOLECULAR CELL (2005)
Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism:: Evidence of a common founder across European populations
J Kachergus et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
Structure of the armadillo repeat domain of plakophilin 1
HJ Choi et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
A putative Ca2+ and calmodulin-dependent protein kinase required for bacterial and fungal symbioses
J Lévy et al.
SCIENCE (2004)
Structural principles of Leucine-Rich repeat (LRR) proteins
P Enkhbayar et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2004)
A rapid method for determining protein kinase phosphorylation specificity
JE Hutti et al.
NATURE METHODS (2004)
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
C Paisán-Ruíz et al.
NEURON (2004)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)
Structural basis for recognition of 2′,5′-linked oligoadenylates by human ribonuclease L
N Tanaka et al.
EMBO JOURNAL (2004)
Roc, a Ras/GTPase domain in complex proteins
L Bosgraaf et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2003)
The crystal structure of polygalacturonase-inhibiting protein (PGIP), a leucine-rich repeat protein involved in plant defense
A Di Matteo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Crystal structure of a 12 ANK repeat stack from human ankyrinR
P Michaely et al.
EMBO JOURNAL (2002)
RanGAP mediates GTP hydrolysis without an arginine finger
MJ Seewald et al.
NATURE (2002)
WD-repeat proteins: structure characteristics, biological function, and their involvement in human diseases
D Li et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2001)
Crystal structure of the ankyrin repeat domain of Bcl-3:: a unique member of the IκB protein family
F Michel et al.
EMBO JOURNAL (2001)
Comparison of ARM and HEAT protein repeats
MA Andrade et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Identification of a carboxyl-terminal diaphanous-related formin homology protein autoregulatory domain
AS Alberts
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors
PD Jeffrey et al.
GENES & DEVELOPMENT (2000)
Crystal structure of a plant ribonuclease, RNase LE
N Tanaka et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
Crystallographic analysis of the specific yet versatile recognition of distinct nuclear localization signals by karyopherin α
E Conti et al.
STRUCTURE (2000)
分享论文
